Late isolated ocular toxoplasmosis in a belatacept-treated kidney transplant patient.
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.
Luca
L
Lanfranco
Department of Ophthalmology, CHU Purpan, Toulouse, France.
Priscille
P
Olle Delahaye
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.|Université Paul Sabatier, Toulouse, France.
Gaelle
G
Dorr
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.
Arnaud
A
Del Bello
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.|Université Paul Sabatier, Toulouse, France.|INSERM U1043, IFR-BMT, CHU Purpan, Toulouse, France.
Nassim
N
Kamar
D000069594:Abatacept / Q000009:adverse effects* / Q000627:therapeutic use*; D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use; D005654:Fundus Oculi; D006084:Graft Rejection; D006801:Humans; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D051437:Renal Insufficiency / Q000276:immunology / Q000601:surgery; D014122:Toxoplasma / Q000302:isolation & purification; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome; D014657:Vasculitis / Q000188:drug therapy
D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D003520:Cyclophosphamide